Glipizide Oral Suspension (Anhydrous)
Glipizide is a compounded formulation containing Glipizide, prepared by Mixlab for veterinary use. Available by prescription.
How to Give Anhydrous Oral Suspension
Oral Suspension (Anhydrous) is a liquid medication that does not contain water in its base. This might be an oil-based or other special base to help stabilize the medicine. It will look like a regular liquid medication, but often needs a good shake because the drug can settle. Here's how to give it:
- Shake well each time to mix the medication (5-10 seconds).
- Measure the dose using the syringe/dropper provided or one recommended by your vet. Insert the top of the oral syringe into the bottle adapter. Turn the bottle upside down and pull the plunger until the medicine reaches the volume required
- Hold your pet steady: a towel or helper can assist with squirmy pets.
- Administer the dose slowly into the side of the mouth. Allow small pauses if needed for swallowing.
- Raise the head slightly to help the medication go down and clean any spills with a little water or tissue.
- Praise your pet and offer a treat or water (unless advised against feeding right after).
- Clean the syringe with water immediately after use. Store the bottle as directed, out of sunlight.
- Consistency is key: Shake each time, measure accurately, and contact your vet if any issues arise.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Glipizide is a second-generation sulfonylurea utilized in veterinary medicine for the management of blood glucose levels. It is a prescription medication available for use in feline patients, frequently considered by veterinarians for cats presented with type 2 diabetes mellitus when insulin therapy is not prioritized or feasible. Your veterinarian will determine the clinical appropriateness of glipizide based on your cat's health status and diagnostic profile.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, glipizide manages blood sugar by stimulating the release of insulin from functioning pancreatic beta cells. Commonly observed effects include localized digestive changes such as vomiting or a temporary decrease in appetite. Because it manages insulin release, your veterinarian will monitor for observational signs of low blood sugar (hypoglycemia). It is typically used with caution in patients with known severe renal or hepatic impairment. Owners should monitor their cat for any unusual weakness or fainting and contact their veterinarian promptly.
Yes. Glipizide is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all professional standards are met before dispensing.
Yes. Mixlab specializes in compounding glipizide into customized strengths and flavored oral formats, such as flavored oral liquids or treats, to suit the specific needs of your cat.
Veterinarians discuss glipizide because it signals the pancreas to release more of the body’s natural insulin. This provides a method for managing blood sugar levels in some diabetic cats.
Your veterinarian will recommend regular blood glucose checks and periodic check-ups to monitor pancreatic function. This monitoring ensures the management approach remains safe for your pet.
Unusual weakness or coordination changes can be observational signs of low blood sugar. If you notice these shifts, contact your veterinarian immediately for a clinical review of the management plan.
